Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response

Journal of Pharmaceutical Sciences

Volumn 85, Issue 12, 1996, Pages 1346-1349

  Cleland, Jeffrey L ^a   Barrón, Lorena ^a   Berman, Phillip W ^a   Daugherty, Ann ^a   Gregory, Tim ^a   Lim, Amy ^a   Vennari, Joann ^a   Wrin, Terri ^a   Powell, Michael F ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; POLYGLACTIN; RECOMBINANT PROTEIN; VIRUS VACCINE;

ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BOLUS INJECTION; DRUG FORMULATION; GUINEA PIG; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION; VACCINE PRODUCTION; VIRUS NEUTRALIZATION;

EID: 0030472704     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960047b     Document Type: Article

References (16)

1. Haigwood, N. L.; Nara, P. L.; Brooks, P.; Van-Nest, G. A.; Ott, G. A.; Higgins, K. W.; Dunlop, N.; Scandella, C. J.; Eichberg, J. W.; Steimer, K. S. J. Virol. 1992, 66, 172-182.
2. Cleland, J. L.; Powell, M. F.; Lim, A.; Barron, L.; Berman, P. W.; Eastman, D. J.; Nunberg, J. H.; Wrin, T.; Vennari, J. C. AIDS Res. Human Retrovir. 1994, 10, S21-S26.
3. Cleland, J. L.; Powell, M. F.; Lim, A.; Barrón, L.; Berman, P. W.; Nunberg, J. H.; Eastman, D. J.; Wrin, T.; Vennari, J. C.; Murthy, K. K.; Kensil, C. R.; Wu, J. Y. Proc. Int. Symp. Controlled Release Bioact. Mater. 1995, 22, 570-571.
4. Cleland, J. L. In Vaccine Design: The Subunit and Adjuvant Approach; Powell, M. F., Newman, M., Eds.; Plenum: New York, 1995; pp 439-472.
5. Powell, M. F.; Cleland, J. L.; Eastman, D. J.; Lim, A.; Newman, M. J.; Nunberg, J. H.; Weissburg, R. P.; Vennari, J. C.; Wrin, T.; Berman, P. W. AIDS Res. Human Retrovir. 1994, 10, S105-S108.
6. Kensil, C. H.; Patel, U.; Lennick, M.; Marciani, D. J. Immunol. 1991, 146, 431-437.
7. Stieneker, F.; Kreuter, J. In Formulation and Delivery of Proteins and Peptides; Cleland, J. L.; Langer, R., Eds.; American Chemical Society: Washington, D.C., 1994; Vol. 567, pp 306-321.
8. Nakamura, G.; Byrn, R.; Rosenthal, K.; Porter, J. P.; Hobbs, M. R.; Riddle, L.; Eastman, D. J.; Dowbenko, D.; Gregory, T. J.; Fendly, B.; Berman, P. W. AIDS Res. Human Retrovir. 1992, 8, 1875.
9. Lasky, L. A.; Nakamura, G.; Smith, D. H.; Fennie, C.; Shimasaki, C.; Patzer, E.; Berman, P. W.; Gregory, T. J.; Capon, D. J. Cell 1987, 50, 975-985.
10. Powell, M. F.; Eastman, D. J.; Lim, A.; Lucas, C.; Peterson, M.; Vennari, J.; Weissburg, R. P.; Wrin, T.; Kensil, C.; Newman, M. J.; Nunberg, J. H.; Cleland, J. L.; Gregory, T.; Berman, P. W. AIDS Human Retr. Vir. 1995, 11, 203-209.
11. Berman, P. W.; Eastman, D. J.; Wilkes, D.; Nakamura, G. R.; Izu, A.; Schwartz, D.; Belshe, R.; Byrn, R. AIDS 1994, 8, 591-601.
12. Robertson, G. A.; Kostek, B. M.; Schleif, W. A.; Lewis, J. A.; Emini, E. A. J. Virol. Meth. 1988, 20, 195-202.
13. Mosmann, T. J. Immunol. Meth. 1983, 65, 55-63.
14. Anderson, K. P.; Lucas, C.; Hanson, C. V.; Londe, H. F.; Izu, A.; Gregory, T.; Ammann, A.; Berman, P. W.; Eichberg, J. W. J. Infect. Dis. 1989, 160, 960-969.
15. Powell, M. F.; Newman, M. J. Vaccine Design: The Subunit and Adjuvant Approach; Plenum: New York, 1995; p 949.
16. Vogel, F. R.; Powell, M. F. In Vaccine Design: The Subunit and Adjuvant Approach; Powell, M. F.; Newman, M. J.; Eds.; Plenum: New York, 1995; pp 141-228.